Sciences of Pharmacy
Open Access

Sciences of Pharmacy

sciphar@etflin.com (Managing Editor)
Preclinical and clinical drug developmentDrug deliveryPharmaceutical formulationPharmacodynamicsPharmacokineticsDrug metabolismPharmacogeneticsGene-based therapyCell-based therapyProtein-based therapyDrug classesDrug nomenclatureDrug-drug interactionAdverse drug reactionDrug toxicityPharmacovigilancePharmacoepidemiologyPharmacoeconomicsClinical pharmacy

Official Affiliation

Affiliation logo
Academic Excellence

Editorial Board

Demography

4
Continents
13
Countries
26
Cities
30
Total Experts

editor-in-chief

R

Rina Wijayanti

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Islam Sultan Agung, Kaligawe Raya Street Km. 4, Semarang, Indonesia

Semarang, Indonesia
Pharmacognosy; Herbal medicine

advisory-editor

Y

Yashwant V Pathak

USF Health Taneja College of Pharmacy, University of South Florida, Florida 33612, USA

Florida, United States
Nanotechnology; Physical chemistry; Polymer chemistry; Nutraceuticals
J

Jittima Amie Luckanagul

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand

Bangkok, Thailand
Polymers synthesis; Liposomal delivery system; Vaccines; Nanoparticles
M

Marline Abdassah Bratadiredja

Departement of Pharmaceutic and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia

Sumedang, Indonesia
Transdermal drug delivery; Cosmetics; Extract formulation
S

Saule Kutymovna Ordabaeva

Department of Pharmaceutical and Toxicological Chemistry, Faculty of Pharmacy, South Kazakhstan Medical Academy, Shymkent 160001, Kazakhstan

Shymkent, Kazakhstan
Pharmaceutical production technology; Pharmaceutical ecology

sectional-editor

Section: Drug Discovery and Development

E

Elena Bakhrushina

Departament of Pharmaceutical Technology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia

Moscow, Russia
Controlled drug delivery; Ocular drug delivery; Pharmaceutical biotechnology; Spray drying; Pharmacokinetics; Biopharmaceutics; Industrial pharmacy; Pharmaceutical analysis; Targeted drug delivery; Solid dosage forms
A

Ahmed Mahal

Department of Medical BioChemical Analysis, Faculty of Health Technology, Cihan University, Erbil 44001, Iraq

Kurdistan, Iraq
Medicinal Chemistry
A

Adeleye Ademola Olutayo

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Olabisi Onabanjo University, Ago-Iwoye, Nigeria

Ago-Iwoye, Nigeria
Drug formulation; Controlled drug delivery; Preformulation; Drug stability; Tablet; Pharmaceutical formulation; Medical nanotechnology; Topical administration
S

Sayani Bhattacharyya

Krupanidhi College of Pharmacy, Bengaluru, Karnataka 560035, India

Karnataka, India
Solid state behaviour; Cocrystallization; Mesoporous materials; Oral disintegrating films
G

Garnadi Jafar

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung City 40614, Indonesia

Bandung, Indonesia
Herbal formulation
B

Burak Kuzu

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Van Yüzüncü Yıl University, 65090 Tuşba/Van, Turkey

Tuşba/Van, Turkey
Medicinal chemistry; Organometallic Chemistry; Organic Chemistry
E

Ebrahim Tavakoli

Department of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan-817467344, Iran

Isfahan, Iran
Stem cell therapy; Tissue replacement via advanced materials; and Drug delivery nano-carrier systems
A

Abdelrahman I. Rezk

Department of Bionanosystem Engineering, Graduate School, Chonbuk National University, Jeonju-Si 54896, Republic of Korea

Jeonju-Si, Republic of Korea
Biomedical devices; Nanomedicine
N

Nurhasni Hasan

Department of Pharmaceutical Science and Technology, Faculty of Pharmacy, Hasanuddin University, Makassar-90245, Indonesia

Makassar, Indonesia
Nanoparticulate-based drug delivery system; advanced hydrogel-based drug delivery system
R

Rifka Nurul Utami

Faculty of Pharmacy, Universitas Hasanuddin, Jl. Perintis Kemerdekaan KM 10 Makassar 90245, Indonesia

Makassar, Indonesia
Pharmaceutical formulations; nanomedicine; drug delivery

Section: Fundamental and Clinical Pharmacology

P

Pilli Govindaiah

Department of Pathology, School of Medicine, Wayne State University, Detroit, Michigan 48202, USA

Michigan, United States
Medicinal Chemistry; Cancer
Z

Zilin Wei

Key Laboratory of Risk Assessment and Control for Environment & Food Safety, Tianjin Institute of Environmental & Operational Medicine, Tianjin 300050, China

Tianjin, China
Microbiology; Genetics; Bioinformatics
M

Mustafa Azizoğlu

Department of Stem Cell and Tissue Engineering, Istinye University, 34396 Istanbul, Turkey

Istanbul, Turkey
Stem cell; Tissue engineering; Minimal invasive surgery
F

Fifteen Aprila Fajrin

Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jember, Jember - 68121, Indonesia

Jember, Indonesia
Pharmacology; Neuropharmacology; Etnopharmacology; Molecular Pharmacology

Section: Pharmacy Practice, Management, and Administrative

M

Mohammad B. Nusair

Sociobehavioral and Administrative Pharmacy Department, Nova Southeastern University, Florida 33314, United States

Florida, United States
Health Care Management; Health Services Research; Pharmaceutical Care; Mixed Methods; Quantitative and Qualitative Research; Deprescriptions; Polypharmacy; Pharmacy Education
T

Taehwan Park

Pharmacy Administration and Public Health, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States

New York, United States
Pharmacoeconomic, pharmacoepidemiology, social pharmacy, digital pharmacy, telepharmacy, big pharmacy data
R

Ruth Jeminiwa

Department of Pharmacy Practice, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia 19144, United States

Philadelphia, United States
Health outcomes research (behavioral health, digital health, pharmacoeconomics
I

Indriyati Hadi Sulistyaningrum

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Islam Sultan Agung, Kaligawe Raya Street Km. 4, Semarang, Indonesia

Semarang, Indonesia
Clinical pharmacy; Community pharmacy

Section: Pharmacoinformatics

A

Ahmed Mohsin Mahdi

Assistant Dean of the College of Computer Science and Information Technology, Al-Qadisiyah University, Iraq

Al Diwaniyah, Iraq
Genetic aericultural analysis; Brain EEG clustering; Machine learning
E

Ernest Domanaanmwi Ganaa

ICT department of Hilla Limann Technical University, Ghana

WA, Ghana
Big data in pharmacology, toxicology, and pharmaceutics; Machine learning; Pattern recognition; and Dimensionality reduction
M

Morteza Rabiei

Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah 6714414971, Iran

Kermanshah , Iran
Server; Distributed databases; Bioinspired engineering and biomimetic design

managing-editor

A

Angi Nadya Bestari

Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta 55281, Indonesia

Yogyakarta, Indonesia
K

Keerthic Aswin

CSIR-GATE JRF, Institute of Genomics and Integrative Biology, New Delhi, India

New Delhi, India
D

Dhanang Prawira Nugraha

Department of Pharmacy, Faculty of Sciences and Technology, Ma Chung University, Malang 65151, Indonesia

Malang, Indonesia
G

Georgy Prosvirkin

Peoples' Friendship University of Russia (RUDN University), Moscow 117198, Russia

Moscow, Russia

Journal Key Facts

Publishing Fee (APC)

IDR 1100000

Open Access License

CC BY 4.0

Language

English

Abstracting & Indexing
SintaCAS

Overview

Sciences of Pharmacy (SciPhar) is a peer-reviewed open-access journal of pharmacy owned and published by ETFLIN. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript. Sciphar publishes 4 issues a year. Sciences of Pharmacy is affiliated with Faculty of Pharmacy, Universitas Islam Sultan Agung.

Authors from countries other than Indonesia are not charged a publication fee until further notice.

Published 4 issues a year (March, June, September and December) with a continuous publishing model — accepted articles are immediately assigned to the active issue.
Eligible Article Types: Case Report, Case Series, Clinical Trial, Editorial, Letter to Editor, Meta Analysis, Mini Review, Opinion/Perspective, Research Article, Review, Technical Note
Current Issue

Latest Articles

Recently published research articles, review papers, and technical notes from the current volume of the journal.

  • research article

    Griess Assay Evaluation of Nitric Oxide Scavenging by a Multi-Extract Emulgel for Topical Steroid Withdrawal

    Wahyu Bachtiar, Tyssa Mariyana, Nurul Hidayatri, Bheta Sari Dewi, Ayu Werawati

    Topical steroid withdrawal (TSW) is an iatrogenic dermatosis following prolonged topical corticosteroid use, with limited non-steroidal alternatives. This study developed a multi-extract emulgel containing Andrographis paniculata, Tinospora cordifolia, Curcuma longa, and Piper nigrum and screened its nitric oxide (NO)-scavenging activity. Standardized ethanolic extracts were incorporated into eight emulgels (F1–F8) using a 2³ full factorial design, varying A. paniculata (3–5%), T. cordifolia (4–6%), and C. longa (4–6%) with P. nigrum fixed at 10%. Physical characterization showed homogeneous oil-in-water emulgels with pH 5.26–5.90, spreadability 6.7–6.8 cm, and viscosity 12,560–17,120 cP. IC₅₀ values for all formulations exceeded the highest tested concentration (100 µg/mL) without reaching the concentration-response curve plateau, and are reported as > 100 µg/mL compared to 18.48 µg/mL for ascorbic acid. Descriptive ranking placed F4 first, followed by F7 and F8. Exploratory factorial analysis indicated that C. longa levels and the A. paniculata × T. cordifolia interaction drove IC₅₀ variation, showing that higher extract loading did not enhance activity. Because this cell-free assay reflects only direct chemical NO scavenging, findings are strictly preliminary and descriptive. Future validation requires independent runs across an expanded concentration range capturing the full upper plateau. F4 is tentatively proposed as the lead formulation for confirmatory testing and subsequent stability, cell-based, and in vivo studies.

    Sciences of Pharmacy

    1 Nov 2026
    16 pages
  • review

    Solid Lipid Nanoparticles as Delivery Systems for Plant-Derived Phytochemicals in Cancer Therapy: A Systematic Review

    Ade Abiyyatun Mahdiyyah, Mazaya Fadhila, Moh. Firman Irwanto, Ayu Rana Esadini, Wafa Wafa, Alfa Frista Arta, Ira Novita Sari

    Solid lipid nanoparticles (SLNs) have been investigated as lipid-based delivery systems to improve the solubility, stability, bioavailability, and delivery of plant-derived phytochemicals to tumors for cancer therapy. However, the available evidence remains heterogeneous and predominantly preclinical. This systematic review aimed to evaluate the formulation strategies, physicochemical characteristics, and therapeutic applications of phytochemical-loaded SLNs in cancer therapy. The review followed the PRISMA 2020 guidelines. Original research articles in English investigating phytochemical-loaded SLNs for cancer therapy were included. Data on formulation composition, preparation methods, physicochemical properties, drug release, in vitro anticancer activity, pharmacokinetics, biodistribution, and in vivo antitumor efficacy were extracted. Risk of bias was assessed using the SYRCLE tool for animal studies and an adapted checklist for in vitro studies. Thirty one articles were included in the qualitative synthesis. Most SLNs had particle sizes in the nanoscale range, approximately 50-350 nm, with encapsulation efficiencies of 43-99% and sustained-release profiles. Encapsulation generally improved cellular uptake and in vitro cytotoxicity in several cancer models. However, evidence of improved bioavailability, active tumor targeting, and in vivo antitumor efficacy remained limited and heterogeneous. Surface modification enhanced cellular uptake or organ accumulation in some studies, but validated tumor-specific targeting was not consistently demonstrated. Overall, phytochemical-loaded SLNs demonstrate potential as delivery platforms; however, clinical translation requires standardized formulations, robust in vivo studies, comprehensive safety evaluations, and clinical trials.

    Sciences of Pharmacy

    7 Nov 2026
    19 pages
  • research article

    Solid Preservative Preparation from Decolorized Ethanolic Extract of Ginggiang (Leea aequata L.): A 90-Day Subchronic Toxicity Study in Rats

    Purwaniati Purwaniati, Rahmana Emran Kartasasmita, Maria Immaculata Iwo, Muhamad Insanu

    Natural preservatives derived from medicinal plants require a thorough safety evaluation before they can be used in food. Ginggiang has traditionally been used by the Kuta indigenous community in Ciamis, West Java, Indonesia, to preserve palm sap; however, its safety profile has not been evaluated. In this study, a solid preservative preparation was developed from the decolorized ethanolic extract of ginggiang leaves (SPP-ED), and its safety profile was assessed after repeated oral administration. The study focused on subchronic oral toxicity and identified the target organs affected by repeated exposure to SPP-ED. In a 90-day experiment, both male and female Wistar rats received SPP-ED at doses of 45, 150, or 1500 mg/kg body weight per day. Satellite groups were included to evaluate recovery. Various parameters, including behavioral, hematological, biochemical, urinalysis, organ index, and histopathological evaluations, were systematically analyzed. No mortality was observed during the study. The results showed that subchronic exposure to SPP-ED had sex-specific effects: female rats experienced renal alterations, characterized by changes in urinalysis, elevated blood urea nitrogen and creatinine levels, and signs of tubular degeneration. In contrast, male rats exhibited pulmonary changes, including an increased lung-to-body weight ratio, alveolitis, and fibrosis. The D1 dose (45 mg/kg body weight/day) was the lowest dose at which potentially adverse histopathological changes were observed; however, a definitive NOAEL and LOAEL could not be established. Further studies using lower dose levels are warranted to better characterize the dose-response relationship and establish the NOAEL and LOAEL of SPP-ED.

    Sciences of Pharmacy

    2 Nov 2026
    13 pages
  • research article

    Polypharmacy and Potentially Inappropriate Medications (PIMs) in Older Adults with Cardiometabolic Disease: A STOPP/START Criteria-Based Analysis

    Yeni Farida, Rizki Amalia Taufany

    Potentially inappropriate medications (PIMs) are a common issue in older adults. Older adults often require multiple medications to manage cardiometabolic disease. This study aimed to identify potentially inappropriate medications and potential inappropriate omissions using STOPP/START criteria in older adult patients with cardiometabolic disease. We conducted an observational analytical study using retrospective data at a secondary care teaching hospital in Sukoharjo, Central Java. We included older adult patients admitted to the inpatient wards between January and June 2022. The prescriptions were analyzed using the STOPP/START Criteria 2016. The Chi-square test analysis was performed to examine the association between the number of drugs and the occurrence of PIMs. We included 97 geriatric inpatients. All patients received at least 5 drugs during each admission, 35.06% were classified as having hyperpolypharmacy. Among the 97 patients, 36.08% had PIM prescriptions, and 29.89% had PPOs. There was a statistically significant association between the number of drugs and PIMs in older adults. Compared with patients receiving > 10 medications, those receiving 5–10 medications had lower odds of PIM use (OR 0.409, 95% CI 0.173–0.969; p = 0.040). These findings highlight high medication burden as an important marker for targeted medication review in geriatric inpatients, particularly those with cardiometabolic multimorbidity.

    Sciences of Pharmacy

    31 Oct 2026
    10 pages
  • research article

    Comparison of PEG 4000 and 6000 in Solid Dispersion of Tadalafil Prepared by Melting Method

    Moh. Firman Irwanto, Arif Budi Setianto, Ade Abiyyatun Mahdiyyah, Maratun Shoaliha, Amzal Mortin Andas, Ashar Prima, Indah Puspitasari, Andi Tenri Nurwahidah, Fauziah H Wada

    Tadalafil is a BCS Class II drug with very low aqueous solubility, limiting its oral bioavailability. Solid dispersion technology using polyethylene glycol (PEG) is an effective strategy to enhance solubility. This study aimed to compare the effectiveness of PEG 4000 and PEG 6000 as carriers in amorphous solid dispersions of tadalafil prepared by the melting method. Solid dispersions were prepared at weight ratios (tadalafil:polymer) of 1:1, 1:2, 1:3, and 1:4 for both PEG 4000 and PEG 6000 using the fusion technique (70 °C). The formulations were characterized by Powder X-Ray Diffraction (PXRD), Differential Scanning Calorimetry (DSC), and Fourier Transform Infrared (FTIR) spectroscopy. Solubility studies were conducted in distilled water and phosphate buffer (pH 6.8) and analyzed via a validated HPLC method. Solid dispersions with PEG 6000 at a 1:3 ratio (F7) exhibited the highest solubility enhancement, reaching 16.08 ± 0.6 µg/mL in water. For PEG 4000, the 1:2 ratio (F2) was optimal (8.20 ± 1.3 µg/mL). PXRD and DSC analyses confirmed the transformation of crystalline tadalafil into an amorphous state within the polymer matrix. FTIR spectra indicated shifts in N-H and C=O bands, suggesting hydrogen bond formation. In conclusion, PEG 6000 produced a superior solid dispersion for tadalafil compared to PEG 4000. The primary mechanism is the formation of an amorphous system stabilized by hydrogen bonding. This study provides a formulation basis for improving the oral delivery of tadalafil.

    Sciences of Pharmacy

    2 Nov 2026
    9 pages